deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01343667

GORE Flow Reversal System and GORE Embolic Filter Extension Study (FREEDOM)

The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes

Sponsor: W.L.Gore & Associates

Updated 9 times since 2017 Last updated: Jan 22, 2016 Started: Apr 30, 2011 Primary completion: Nov 30, 2013 Completion: Jan 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Arterial Occlusive Diseases and Brain Diseases and is currently completed. W.L.Gore & Associates leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 8 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  5. Dec 2022 — Jan 2023 [monthly]

    Completed NA

Show 4 earlier versions
  1. Jan 2021 — Dec 2022 [monthly]

    Completed NA

  2. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  3. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • W.L.Gore & Associates
Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .